Evidence map›Paper›PMID 42481784›Full record

ArticleDiscover mental health2026

Validity and reliability of the Persian version of the Alzheimer's Disease Knowledge Scale among Iranian healthcare professionals and students.

Mina Aghaei, Omid Gheisavandi, Brian D Carpenter, Zahra Vahabi, Farshad Sharifi, Farnaz Etesam

Abstract read
PubMed Publisher
In one paragraph

Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mina AghaeiThe MARCS Institute for Brain, Behaviour and Development, Western Sydney University, Penrith, NSW, Australia.
Omid GheisavandiStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Brian D CarpenterDepartment of Psychological & Brain Sciences, Washington University, St. Louis, USA.
Zahra VahabiDepartment of Psychiatry, Cognitive Neurology and Neuropsychiatry Division, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farshad SharifiElderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farnaz EtesamDepartment of Psychiatry, Psychosomatic Medicine Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. f-etesam@sina.tums.ac.ir.ORCID http://orcid.org/0000-0002-4083-4216

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the leading cause of dementia worldwide. With rising prevalence in countries such as Iran, assessing healthcare professionals' knowledge of AD is essential. This study translated and adapted the Alzheimer's Disease Knowledge Scale (ADKS) into Persian and provided preliminary evidence of validity and reliability. A cross-sectional study was conducted with 304 healthcare professionals and students. The mean Persian version of the Alzheimer's Disease Knowledge Scale (ADKS-P) score was 20.27 (standard deviation (SD) = 3.62; possible range 0-30). The ADKS-P was developed using forward-backward translation, expert review, and pilot testing. Content validity, item-level performance, internal consistency estimated with Kuder-Richardson Formula 20 (KR-20), and two-week test-retest reliability were assessed. Known-groups validity was examined through education, occupation, and familiarity with dementia. All items met the critical Content Validity Ratio (CVR) threshold. Internal consistency was modest (KR-20 = 0.64), test-retest reliability was moderate (r = 0.53, p = 0.016), and several items showed weak discrimination (item-total r < 0.20 for 15 items; item 24 r = - 0.05). Higher ADKS-P scores were associated with greater education, professional role, and dementia familiarity. The ADKS-P offers a preliminary, culturally adapted tool for group-level baseline knowledge assessment in Persian-speaking contexts. Further refinement and validation are recommended before broader application.The study was approved by the ethics committee of the Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1401.202).

Indexed as

Alzheimer’s diseaseAlzheimer’s Disease Knowledge Scale (ADKS)Cross-cultural adaptationDementia knowledgeHealthcare professionalsPsychometric validation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.